King Pharmaceuticals KG Diversified Legacy Segment — Net premiums earned
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PremiumsEarnedNet.
The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's diversified legacy segment — net premiums earned.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's diversified legacy segment — net premiums earned?
- King Pharmaceuticals (KG) reported diversified legacy segment — net premiums earned of $867K in Q1 2026.
- What does diversified legacy segment — net premiums earned mean?
- This metric reflects the portion of net premiums written that is recognized as revenue by the Diversified Legacy Segment over the policy period. It represents the actual insurance coverage provided by the segment during the reporting timeframe, net of reinsurance. This is a primary measure of the segment's realized top-line performance and operational scale.